
Piramal Pharma Solutions (PPS), the Contract Development and Manufacturing Organization (CDMO) of Piramal Pharma Limited, will acquire API manufacturer Hemmo Pharmaceuticals for Rs 775 crore.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OeMig0
via
IFTTT
0 comments:
Post a Comment